{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:23:23Z","timestamp":1790101403691,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clgc.2024.102101","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T03:22:12Z","timestamp":1714015332000},"page":"102101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review"],"prefix":"10.1016","volume":"22","author":[{"given":"Zhilin Liu Peter","family":"Guang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"R\u00f8der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Brasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2024.102101_bib0001","unstructured":"Lar\u00f8nningen S., Ferlay J., Bray F. et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 9.2 (23.06.2022). Association of the Nordic Cancer Registries. Cancer Registry of Norway (2022). Available at: https:\/\/nordcan.iarc.fr\/en\/database Accessed: July 30, 2022."},{"key":"10.1016\/j.clgc.2024.102101_bib0002","unstructured":"Global Cancer Observatory: Cancer Today. Lyon, France: International agency for research on cancer. Available at: https:\/\/nordcan.iarc.fr\/en\/database Accessed: July 30, 2022"},{"key":"10.1016\/j.clgc.2024.102101_bib0003","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.urology.2003.09.020","article-title":"High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience","volume":"63","author":"Blana","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2024.102101_bib0004","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/iju.13581","article-title":"Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence","volume":"25","author":"Chen","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.pcan.4500901","article-title":"High-intensity focused ultrasound therapy for clinically localized prostate cancer","volume":"9","author":"Lee","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2024.102101_bib0006","first-page":"127","article-title":"Whole-gland ablation therapy versus active surveillance for low-risk prostate cancer: a prospective study","volume":"73","author":"Enikeev","year":"2020","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/186782","article-title":"Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes","volume":"2014","author":"Limani","year":"2014","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.clgc.2024.102101_bib0009","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1442-2042.2010.02568.x","article-title":"Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study","volume":"17","author":"Shoji","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/JU.0000000000002759","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline. Part III: principles of radiation and future directions","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0014","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"The BMJ"},{"key":"10.1016\/j.clgc.2024.102101_bib0015","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clgc.2024.102101_bib0016","first-page":"1035","article-title":"Consensus statement: guidelines for psa following radiation therapy","volume":"37","year":"1997","journal-title":"Int. J. Radiation Oncology Biol. Phys."},{"key":"10.1016\/j.clgc.2024.102101_bib0017","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1464-410X.2009.08518.x","article-title":"High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure","volume":"104","author":"Blana","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0018","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.ju.0000152556.53602.64","article-title":"Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis","volume":"173","author":"Horwitz","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0019","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000658-200206000-00007","article-title":"Quality of complication reporting in the surgical literature","volume":"235","author":"Martin","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.clgc.2024.102101_bib0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.urology.2008.06.062","article-title":"Eight years\u2019 experience with high-intensity focused ultrasonography for treatment of localized prostate cancer","volume":"72","author":"Blana","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2024.102101_bib0021","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000330909","article-title":"Clinically significant urethral stricture and\/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancer","volume":"87","author":"Komura","year":"2011","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0022","first-page":"189","article-title":"Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes","volume":"83","author":"Kazumasa","year":"2012","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clgc.2024.102101_bib0023","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00345-013-1215-z","article-title":"Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy","volume":"32","author":"Komura","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0024","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/pcan.2009.57","article-title":"Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use","volume":"13","author":"Ripert","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2024.102101_bib0025","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1464-410X.2010.09710.x","article-title":"Six years\u2019 experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new \u2018Stuttgart\u2019 definition for biochemical failure","volume":"107","author":"Ripert","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1464-410X.2009.08355.x","article-title":"High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up","volume":"104","author":"Challacombe","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0027","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.eururo.2010.06.037","article-title":"Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients","volume":"58","author":"Crouzet","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0028","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1464-410X.2012.10945.x","article-title":"Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology","volume":"110","author":"Pinthus","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejso.2017.11.008","article-title":"Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: a propensity score analysis","volume":"44","author":"Capogrosso","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clgc.2024.102101_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/350324","article-title":"High intensity focused ultrasound versus brachytherapy for the treatment of localized prostate cancer: a matched-pair analysis","volume":"2015","author":"Aoun","year":"2015","journal-title":"Adv Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0031","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/iju.12876","article-title":"Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: functional and oncological outcomes","volume":"22","author":"Shoji","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0032","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.juro.2013.02.010","article-title":"Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years","volume":"190","author":"Th\u00fcroff","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0033","article-title":"Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: medium-term results from a single centre","volume":"15","author":"Wu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2024.102101_bib0034","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00345-010-0628-1","article-title":"Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer","volume":"29","author":"Fujisue","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.prnil.2016.01.001","article-title":"Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up","volume":"4","author":"Horiuchi","year":"2016","journal-title":"Prostate Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0036","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2006.06369.x","article-title":"The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy","volume":"98","author":"Uchida","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0037","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1464-410X.2006.05864.x","article-title":"Treatment of localized prostate cancer using high-intensity focused ultrasound","volume":"97","author":"Uchida","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0038","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1442-2042.2006.01272.x","article-title":"Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer","volume":"13","author":"Uchida","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0039","first-page":"651","article-title":"Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study","volume":"51","author":"Uchida","year":"2005","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.clgc.2024.102101_bib0040","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/02656736.2021.1945150","article-title":"Analysis of oncological outcomes of whole-gland therapy with high-intensity focused ultrasound for localized prostate cancer in clinical and technical aspects: a retrospective consecutive case-series analysis with a median 5-year follow-up","volume":"38","author":"Shoji","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.clgc.2024.102101_bib0041","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/pcan.2012.10","article-title":"Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry","volume":"15","author":"Blana","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2024.102101_bib0042","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11934-003-0077-0","article-title":"The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection","volume":"4","author":"Chaussy","year":"2003","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.clgc.2024.102101_bib0043","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/089277901300189501","article-title":"Results and side effects of high-intensity focused ultrasound in localized prostate cancer","volume":"15","author":"Chaussy","year":"2001","journal-title":"J Endourol"},{"key":"10.1016\/j.clgc.2024.102101_bib0044","first-page":"108","article-title":"Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry","author":"Ganzer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102101_bib0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00345-008-0286-8","article-title":"Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer","volume":"26","author":"Misra\u00ef","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0046","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.eururo.2006.04.012","article-title":"Control of prostate cancer by transrectal HIFU in 227 patients","volume":"51","author":"Poissonnier","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0047","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/01.ju.0000124880.35944.58","article-title":"Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study","volume":"171","author":"Vallancien","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0048","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11255-022-03156-x","article-title":"Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer","volume":"54","author":"Lo Verde","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clgc.2024.102101_bib0049","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000658-198010000-00005","article-title":"Endoscopic suspension of the vesical neck for urinary incontinence in females: report on 203 consecutive patients","volume":"192","author":"Stamey","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/j.clgc.2024.102101_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/iju.IJU_355_18","article-title":"Biochemical recurrence after radical prostatectomy: current status of its use as a treatment endpoint and early management strategies","volume":"35","author":"McCormick","year":"2019","journal-title":"Indian J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0051","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1677-5538.ibju.2016.0656","article-title":"Biochemical recurrence after radical prostatectomy: what does it mean?","volume":"44","author":"Tourinho-Barbosa","year":"2018","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0052","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102101_bib0053","doi-asserted-by":"crossref","first-page":"e180039","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clgc.2024.102101_bib0054","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2024.102101_bib0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","article-title":"Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial","volume":"15","author":"Dearnaley","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2024.102101_bib0056","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group\/american college of radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2024.102101_bib0057","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clgc.2024.102101_bib0058","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2024.102101_bib0059","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00345-018-2613-z","article-title":"Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis","volume":"37","author":"Rosenhammer","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2024.102101_bib0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T08:32:48Z","timestamp":1718526768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1558767324000727"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102101","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102101"}}